BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22119705)

  • 1. Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: perspective from a developing country.
    Memari AH; Ziaee V; Beygi S; Moshayedi P; Mirfazeli FS
    Res Dev Disabil; 2012; 33(2):563-9. PubMed ID: 22119705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric diagnosis and psychotropic medication prescription patterns in a mental hospital-based child and adolescent psychiatric service in Nigeria.
    Bakare MO; Igwe MN; Odinka PC; Iteke O
    J Health Care Poor Underserved; 2011 Aug; 22(3):751-5. PubMed ID: 21841276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
    Schubart JR; Camacho F; Leslie D
    Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of location on psychotropic treatment practices among pediatricians.
    Segool NK; Meadows T; Roberts H; Thorson R; Dogan R; Evans J; Reisener C
    J Dev Behav Pediatr; 2013 Jan; 34(1):22-30. PubMed ID: 23275055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drug use in late life: a diverse look at an expanding field.
    Blazer D
    Am J Geriatr Pharmacother; 2011 Apr; 9(2):95-6. PubMed ID: 21565708
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
    Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
    Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
    Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
    Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use in US youth with mental disorders.
    Merikangas KR; He JP; Rapoport J; Vitiello B; Olfson M
    JAMA Pediatr; 2013 Feb; 167(2):141-8. PubMed ID: 23403911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication use in community-dwelling older people: pharmacoepidemiology of psychotropic utilisation.
    Schäfers A; Martini N; Moyes S; Hayman K; Zolezzi M; McLean C; Kerse N
    J Prim Health Care; 2014 Dec; 6(4):269-78. PubMed ID: 25485322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing irritability and aggression in autism spectrum disorders in children and adolescents.
    Robb AS
    Dev Disabil Res Rev; 2010; 16(3):258-64. PubMed ID: 20981764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.